Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,804 | 5,740 | 2,977 | 299 | 2,450 |
| Depreciation Amortization | N/A | N/A | N/A | 5 | N/A |
| Accounts receivable | -688 | -803 | 177 | -1,677 | -466 |
| Other Working Capital | 416 | 412 | 1,182 | -512 | -898 |
| Other Operating Activity | -9,485 | -5,862 | -3,668 | -1,217 | -3,828 |
| Operating Cash Flow | $-953 | $-513 | $668 | $-3,102 | $-2,742 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 660 | 400 | N/A | 1,276 | 1,270 |
| Other Financing Activity | -18 | -15 | 0 | -11 | 0 |
| Financing Cash Flow | $642 | $385 | $N/A | $1,265 | $1,270 |
| Beginning Cash Position | 518 | 518 | 518 | 2,355 | 2,355 |
| End Cash Position | 207 | 390 | 1,186 | 518 | 883 |
| Net Cash Flow | $-311 | $-128 | $668 | $-1,839 | $-1,472 |
| Free Cash Flow | |||||
| Operating Cash Flow | -953 | -513 | 668 | -3,102 | -2,742 |
| Free Cash Flow | -953 | -513 | 668 | -3,102 | -2,742 |